Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.

Schedule an appointment today


Advancing Standards of Care Through Collaboration

To advance treatment options for children with pulmonary diseases, UH Rainbow Babies & Children’s collaborates with many nationally-recognized institutions, including Case Western Reserve University School of Medicine.

Together, we’ve been able to achieve scientific discoveries that are now a mainstay of treatment. This collaborative approach to research has also led to new personalized, small-molecule therapies for severe asthma and CF. By testing combinations of drugs, our physicians and researchers have been able to better understand which drugs will likely work best for individual patients.

UH Rainbow Babies & Children’s is also part of an asthma research network called the PrecISE Network, which stands for Precision Interventions for Severe and/or Exacerbation Prone Asthma. Funded by the National Institutes of Health, our pediatric asthma specialists are seeking innovative therapies to help patients when standard therapies are unsuccessful. Our team is researching biological medications or biologics – which will be given by injection to patients with severe asthma. These promising discoveries give hope to our patients – and those that benefit from our research.

The collaboration between basic science, clinical research and patient care continues to yield positive outcomes and long-term rewards for pediatric patients with pulmonary diagnoses.